<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:108px; width:501px; height:652px;"><span style="font-family: Arial,Bold; font-size:10px">Conclusions</span><span style="font-family: Arial; font-size:10px">:  Higher  proportions  of  gamma-linolenic  acid  and  SFA,  especially  myristic  acid,  and 
<br>lower  proportions  of  many  MUFA  and  PUFA  in  plasma  are  associated  with  plasma concentration  of 
<br>leptin in  children.  Fatty  acids  in  plasma  TG  fraction  seem  to  have  the  strongest  associations  with 
<br>plasma leptin concentration. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Protocol registration: </span><span style="font-family: Arial; font-size:10px">Clinical trial number NCT01803776.</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br>Funding:  </span><span style="font-family: Arial; font-size:10px">The  Finnish Cultural  Foundation,  the  Juho  Vainio  Foundation,  the  Finnish  Foundation  of 
<br>Cardiovascular Research. 
<br></span><span style="font-family: Arial,Bold; font-size:11px"> 
<br> 
<br>Short Oral Abstract 12 - Comparison of Glycemic Outcome and Relation to 
<br>Changes in Liver Fat Content in Low -carb vs. Low-fat Dietary Regimes for 
<br>Prediabetic Subjects</span><span style="font-family: Arial; font-size:11px">  
<br></span><span style="font-family: Arial,Bold; font-size:11px">(Stefan Kabisch, Germany) 
<br></span><span style="font-family: Arial,Italic; font-size:11px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Stefan Kabisch</span><span style="font-family: Arial,Italic; font-size:6px">1,2*</span><span style="font-family: Arial,Italic; font-size:10px">, Ulrike Kaiser</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Margrit Kemper</span><span style="font-family: Arial,Italic; font-size:6px">1,2</span><span style="font-family: Arial,Italic; font-size:10px">, Christiana Gerbracht</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Caroline Honig</span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">, Andreas 
<br>F.H. Pfeiffer</span><span style="font-family: Arial,Italic; font-size:6px">1,2,3</span><span style="font-family: Arial,Italic; font-size:10px">.</span><span style="font-family: Arial,BoldItalic; font-size:10px"> 
<br></span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">German Institute of Human Nutrition Potsdam-Rehbrücke, Department of Clinical Nutrition, Nuthetal  
<br></span><span style="font-family: Arial,Italic; font-size:6px">2 </span><span style="font-family: Arial,Italic; font-size:10px">German Center for Diabetes Research (DZD), Munich</span><span style="font-family: Arial,Italic; font-size:6px">  
<br>3 </span><span style="font-family: Arial,Italic; font-size:10px">Charité University Hospital Berlin, Campus Benjamin Franklin, Berlin 
<br>stefan.kabisch@dife.de  
<br></span><span style="font-family: Arial,Bold; font-size:10px"> 
<br>Objective: </span><span style="font-family: Arial; font-size:10px">Dietary strategies basing on the main nutrient components have been widely compared for 
<br>their effectiveness in weight loss, weight maintenance and several metabolic outcomes. However, 
<br>short- and long-term effects on glucose levels and liver fat content are controversially discussed. 
<br>Furthermore, the interaction between weight loss, glycemic improvement and reduction of liver fat 
<br>content is unclear.</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br>Methods: </span><span style="font-family: Arial; font-size:10px">In a subcohort of the Prediabetes Lifestyle Intervention Study (PLIS; n=99) we conducted a 
<br>two-step dietary intervention with two different regimes. The initial three-weeks phase was hypocaloric 
<br>(ca. 1500 kcal/day), the second phase (11 months) was isocaloric. We compared a low-carb regime 
<br>(short term: &lt; 40 g carbohydrates/day, long term: &lt; 40 % of daily energy intake) and a low-fat diet (fat 
<br>intake &lt; 30 % of daily energy intake). Metabolic assessment throughout the study based on 2-hours 
<br>oral glucose tolerance tests and magnetic resonance spectroscopy (liver fat).  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results: </span><span style="font-family: Arial; font-size:10px">While both interventions show a similar statistically significant short-term reduction and long-
<br>term maintenance of glucose levels and liver fat content, only short-term reductions in fasting glucose 
<br>levels appear to be significantly pronounced in the low-carb group (p=0,002). Correlation analysis 
<br>shows, that despite similar magnitude of metabolic changes, liver fat reduction under low-fat diet is 
<br>tightly linked to weight loss (p=0,003), but not in the low-carb group (p=0,17).</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br>Limitations: </span><span style="font-family: Arial; font-size:10px">Our data are preliminary results from an ongoing study. The final subcohort of PLIS will 
<br></span><span style="font-family: Arial; font-size:10px">sum up about 200 subjects with one year of intervention and two additional years of follow-up.</span><span style="font-family: Arial,Bold; font-size:10px"> 
<br>Conclusions: </span><span style="font-family: Arial; font-size:10px">Low-carb and low-fat diets are similarly effective to reduce glycemic parameters and 
<br></span><span style="font-family: Arial; font-size:10px">liver fat content. However, the underlying mechanisms appear to differ regarding dietary composition. 
<br></span><span style="font-family: Arial; font-size:10px">Further analysis will show, under which conditions weight loss is really necessary to achieve metabolic 
<br>improvements. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Protocol registration:</span><span style="font-family: Arial; font-size:10px"> NCT01947595 (clinicaltrials.gov) 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Funding Source:</span><span style="font-family: Arial; font-size:10px"> Federal Ministry of Education and Research  
<br></span><span style="font-family: Arial; font-size:11px"> 
<br> 
<br> 
<br> 
<br> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">61 
<br> 
<br></span></div><div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
